Literature DB >> 24352335

Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.

David Lu1, Paul A Insel.   

Abstract

Tissue fibrosis occurs as a result of the dysregulation of extracellular matrix (ECM) synthesis. Tissue fibroblasts, resident cells responsible for the synthesis and turnover of ECM, are regulated via numerous hormonal and mechanical signals. The release of intracellular nucleotides and their resultant autocrine/paracrine signaling have been shown to play key roles in the homeostatic maintenance of tissue remodeling and in fibrotic response post-injury. Extracellular nucleotides signal through P2 nucleotide and P1 adenosine receptors to activate signaling networks that regulate the proliferation and activity of fibroblasts, which, in turn, influence tissue structure and pathologic remodeling. An important component in the signaling and functional responses of fibroblasts to extracellular ATP and adenosine is the expression and activity of ectonucleotideases that attenuate nucleotide-mediated signaling, and thereby integrate P2 receptor- and subsequent adenosine receptor-initiated responses. Results of studies of the mechanisms of cellular nucleotide release and the effects of this autocrine/paracrine signaling axis on fibroblast-to-myofibroblast conversion and the fibrotic phenotype have advanced understanding of tissue remodeling and fibrosis. This review summarizes recent findings related to purinergic signaling in the regulation of fibroblasts and the development of tissue fibrosis in the heart, lungs, liver, and kidney.

Entities:  

Keywords:  ATP; P2X; P2Y; adenosine; fibrosis; purinergic

Mesh:

Substances:

Year:  2013        PMID: 24352335      PMCID: PMC4010809          DOI: 10.1152/ajpcell.00381.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  148 in total

Review 1.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

Authors:  Eduardo R Lazarowski; Richard C Boucher; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

Review 2.  Structural and functional characterisation of cardiac fibroblasts.

Authors:  Patrizia Camelliti; Thomas K Borg; Peter Kohl
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

Review 3.  Hypoxic activation of adventitial fibroblasts: role in vascular remodeling.

Authors:  Kurt R Stenmark; Evgenia Gerasimovskaya; Raphael A Nemenoff; Mita Das
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

4.  PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.

Authors:  T Oda; Y O Jung; H S Kim; X Cai; J M López-Guisa; Y Ikeda; A A Eddy
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

Review 5.  TGF-beta1 and angiotensin networking in cardiac remodeling.

Authors:  Stephan Rosenkranz
Journal:  Cardiovasc Res       Date:  2004-08-15       Impact factor: 10.787

6.  NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.

Authors:  Gilles Kauffenstein; Annick Drouin; Nathalie Thorin-Trescases; Hélène Bachelard; Bernard Robaye; Pedro D'Orléans-Juste; François Marceau; Eric Thorin; Jean Sévigny
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

Review 7.  The role of epithelial-to-mesenchymal transition in renal fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  J Mol Med (Berl)       Date:  2004-01-30       Impact factor: 4.599

Review 8.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

Review 9.  Therapy for fibrotic diseases: nearing the starting line.

Authors:  Scott L Friedman; Dean Sheppard; Jeremy S Duffield; Shelia Violette
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

10.  Functional compartmentation of endothelial P2Y receptor signaling.

Authors:  Robert A Kaiser; Brian C Oxhorn; Gracie Andrews; Iain L O Buxton
Journal:  Circ Res       Date:  2002-08-23       Impact factor: 17.367

View more
  25 in total

Review 1.  Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).

Authors:  A S Martínez-Ramírez; M Díaz-Muñoz; A Butanda-Ochoa; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2016-11-29       Impact factor: 3.765

2.  Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis.

Authors:  Linda Feldbrügge; Z Gordon Jiang; Eva Csizmadia; Shuji Mitsuhashi; Stephanie Tran; Eric U Yee; Sonja Rothweiler; Kahini A Vaid; Jean Sévigny; Moritz Schmelzle; Yury V Popov; Simon C Robson
Journal:  Purinergic Signal       Date:  2017-11-13       Impact factor: 3.765

Review 3.  Plasma membrane wounding and repair in pulmonary diseases.

Authors:  Xiaofei Cong; Rolf D Hubmayr; Changgong Li; Xiaoli Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-06       Impact factor: 5.464

4.  Whole-Exome Sequencing to Identify Novel Biological Pathways Associated With Infertility After Pelvic Inflammatory Disease.

Authors:  Brandie D Taylor; Xiaojing Zheng; Toni Darville; Wujuan Zhong; Kranti Konganti; Olayinka Abiodun-Ojo; Roberta B Ness; Catherine M O'Connell; Catherine L Haggerty
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

5.  Cardiomyogenesis of embryonic stem cells upon purinergic receptor activation by ADP and ATP.

Authors:  Safoura Mazrouei; Fatemeh Sharifpanah; Mohamed M Bekhite; Hans-Reiner Figulla; Heinrich Sauer; Maria Wartenberg
Journal:  Purinergic Signal       Date:  2015-09-22       Impact factor: 3.765

6.  Loss of vascular expression of nucleoside triphosphate diphosphohydrolase-1/CD39 in hypertension.

Authors:  Charlotte Roy; Julie Tabiasco; Antoine Caillon; Yves Delneste; Jean Merot; Julie Favre; Anne Laure Guihot; Ludovic Martin; Daniele C Nascimento; Bernhard Ryffel; Simon C Robson; Jean Sévigny; Daniel Henrion; Gilles Kauffenstein
Journal:  Purinergic Signal       Date:  2017-12-13       Impact factor: 3.765

Review 7.  Purinergic signaling in scarring.

Authors:  Davide Ferrari; Roberto Gambari; Marco Idzko; Tobias Müller; Cristina Albanesi; Saveria Pastore; Gaetano La Manna; Simon C Robson; Bruce Cronstein
Journal:  FASEB J       Date:  2015-09-02       Impact factor: 5.191

Review 8.  Regulation of Vascular and Renal Function by Metabolite Receptors.

Authors:  János Peti-Peterdi; Bellamkonda K Kishore; Jennifer L Pluznick
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

Review 9.  Update of P2Y receptor pharmacology: IUPHAR Review 27.

Authors:  Kenneth A Jacobson; Esmerilda G Delicado; Christian Gachet; Charles Kennedy; Ivar von Kügelgen; Beibei Li; M Teresa Miras-Portugal; Ivana Novak; Torsten Schöneberg; Raquel Perez-Sen; Doreen Thor; Beili Wu; Zhenlin Yang; Christa E Müller
Journal:  Br J Pharmacol       Date:  2020-04-06       Impact factor: 9.473

10.  RhoA Ambivalently Controls Prominent Myofibroblast Characteritics by Involving Distinct Signaling Routes.

Authors:  Aline Jatho; Svenja Hartmann; Naim Kittana; Felicitas Mügge; Christina M Wuertz; Malte Tiburcy; Wolfram-Hubertus Zimmermann; Dörthe M Katschinski; Susanne Lutz
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.